Heather Marie Lupole, CRNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1000 Evelyn Dr, Millersburg, PA 17061 Phone: 717-232-9971 |
News Archive
Recently, researchers from the University of Melbourne and Immune Therapies Group, Burnet Institute, Melbourne, reported that downregulation of cardiac ACE2 is linked to increased plasma ACE2 activity. This study is summarized in a preprint paper published in medRxiv.
Scientists at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 today presented the first draft reports from three workgroups convened by the National Institute on Aging and the Alzheimer's Association to update the diagnostic criteria for Alzheimer's disease for the first time in 25 years.
Marketing researchers at the University of Arkansas, Villanova University and Marquette University surveyed more than 500 U.S. and Canadian smokers and found that the highly graphic images of the negative consequences of smoking have the greatest impact on smokers' intentions to quit. The most graphic images, such as those showing severe mouth diseases, including disfigured, blackened and cancerous tissue, evoked fear about the consequences of smoking and thus influenced consumer intentions to quit.
As Age-Related Macular Degeneration/Low Vision Awareness Month comes to a close, we're sharing three stories by Bonnielin Swenor, Ph.D., M.P.H., assistant professor of ophthalmology at the Wilmer Eye Institute in the Johns Hopkins University School of Medicine, and an assistant professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.
DiscoveryBioMed, Inc. (DBM), a human cell-based drug discovery company, learned recently that its Cystic Fibrosis Corrector Ligand (CFCL) Drug Discovery program will be funded by the NIH. The two-year award will focus on validation and prioritization of several lead CFCL chemical classes, drugs that correct the most common cystic fibrosis (CF) disease-causing mutation.
› Verified 2 days ago